Haemonetics Corporation
HAE
$78.71
$3.835.12%
NYSE
| 03/28/2026 | 12/27/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.15M | 44.74M | 38.68M | 34.03M | 57.98M |
| Total Depreciation and Amortization | 21.22M | 27.39M | 28.26M | 28.76M | 21.51M |
| Total Amortization of Deferred Charges | 6.10M | -- | -- | -- | 6.70M |
| Total Other Non-Cash Items | 69.84M | 9.63M | 18.29M | 10.09M | -9.34M |
| Change in Net Operating Assets | -6.07M | 11.81M | 26.09M | -55.48M | 39.70M |
| Cash from Operations | 70.94M | 93.56M | 111.32M | 17.40M | 116.56M |
| Capital Expenditure | -17.66M | -6.35M | -5.02M | -3.75M | -15.64M |
| Sale of Property, Plant, and Equipment | 526.00K | 432.00K | 120.00K | 297.00K | 2.45M |
| Cash Acquisitions | -60.18M | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | 43.29M |
| Other Investing Activities | -9.30M | -23.55M | -25.57M | -29.54M | -12.06M |
| Cash from Investing | -86.61M | -29.47M | -30.47M | -33.00M | 18.04M |
| Total Debt Issued | 300.00M | -- | -- | -- | 0.00 |
| Total Debt Repaid | -301.56M | -1.56M | -1.56M | -1.56M | -1.56M |
| Issuance of Common Stock | 122.00K | 3.77M | 63.00K | 3.94M | 140.00K |
| Repurchase of Common Stock | -100.05M | -160.00K | -75.01M | -4.78M | -150.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.00K | -14.00K | -39.00K | -36.00K | -27.00K |
| Cash from Financing | -101.50M | 2.03M | -76.55M | -2.44M | -151.45M |
| Foreign Exchange rate Adjustments | -756.00K | 810.00K | -773.00K | 4.18M | 2.77M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.93M | 66.94M | 3.53M | -13.87M | -14.08M |